Should continuous glucose monitoring be used to manage neonates at risk of hypoglycaemia?

The National Institute for Clinical Excellence (NICE) now recommends that continuous glucose monitoring (CGM) be offered to adults and children with diabetes who are at risk from hypoglycaemia. Hypoglycaemia is common in the neonatal period, and is a preventable cause of poor neurodevelopmental outcome, but is CGM helpful in the management of neonates at risk of hypoglycaemia? Neonatal studies have shown that CGM can detect clinically silent hypoglycaemia, which has been associated with reduced executive and visual function in early childhood. Intervention trials have further shown CGM can support the targeting of glucose levels in high-risk extremely preterm neonates. In spite of significant advances in technology, including smaller sensors, better accuracy and factory calibration, further progress and adoption into clinical practice has been limited as current devices are not designed nor have regulatory approval for the specific needs of the newborn. The use of CGM has the potential to support clinical management, and prevention of hypoglycaemia but must be set within its current limitations. The data CGM provides however also provides an important opportunity to improve our understanding of potential risks of hypoglycaemia and the impact of clinical interventions to prevent it.

[1]  K. Beardsall,et al.  Continuous glucose monitoring during therapeutic hypothermia for hypoxic ischaemic encephalopathy: a feasibility study , 2022, Archives of Disease in Childhood.

[2]  J. Chase,et al.  Association of Neonatal Hypoglycemia With Academic Performance in Mid-Childhood. , 2022, JAMA.

[3]  M. Eriksson,et al.  Assessment and Management of Pain in Preterm Infants: A Practice Update , 2022, Children.

[4]  V. Chau,et al.  Hyperglycemia associated with acute brain injury in neonatal encephalopathy , 2021, NeuroImage: Clinical.

[5]  A. Thankamony,et al.  Continuous Glucose Monitoring in the Management of Neonates With Persistent Hypoglycemia and Congenital Hyperinsulinism , 2021, The Journal of clinical endocrinology and metabolism.

[6]  W. Hay,et al.  The Term Newborn: Hypoglycemia. , 2021, Clinics in perinatology.

[7]  G. Umpierrez,et al.  Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non–Critically Ill Hospitalized Patients With Diabetes , 2021, Diabetes Care.

[8]  F. Cota,et al.  Strict glycaemic control in very low birthweight infants using a continuous glucose monitoring system: a randomised controlled trial , 2021, Archives of Disease in Childhood.

[9]  D. Dunger,et al.  Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial , 2021, The Lancet. Child & adolescent health.

[10]  S. Petrou,et al.  Cost-effectiveness of real time continuous glucose monitoring to target glucose control in preterm infants. , 2021, Seminars in perinatology.

[11]  Fumihiko Namba,et al.  Safety and feasibility of a factory-calibrated continuous glucose monitoring system in term and near-term infants at risk of hypoglycemia , 2021, Turkish archives of pediatrics.

[12]  L. Hooft,et al.  Accuracy of continuous glucose monitoring in preterm infants: a systematic review and meta-analysis , 2020, BMJ Open.

[13]  Daniel R. Hoeber,et al.  Open-Source Technology for Real-Time Continuous Glucose Monitoring in the Neonatal Intensive Care Unit: Case Study in a Neonate With Transient Congenital Hyperinsulinism , 2020, Journal of medical Internet research.

[14]  V. Chau,et al.  Abnormalities in evoked potentials associated with abnormal glycemia and brain injury in neonatal hypoxic-ischemic encephalopathy , 2020, Clinical Neurophysiology.

[15]  E. Budiman,et al.  Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes , 2020, Journal of diabetes science and technology.

[16]  K. Starzec,et al.  Glycemic variability in continuous glucose monitoring negatively correlates with gestational age in very low birth weight infants , 2020, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[17]  K. Stechová,et al.  Continuous glucose monitoring as a screening tool for neonatal hypoglycemia in infants of diabetic mothers , 2020, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[18]  G. Gamble,et al.  Glucose Profiles in Healthy Term Infants in the First 5 Days: The Glucose in Well Babies (GLOW) Study. , 2020, The Journal of pediatrics.

[19]  C. Capristo,et al.  Continuous glucose monitoring profile during therapeutic hypothermia in encephalopathic infants with unfavorable outcome , 2020, Pediatric Research.

[20]  D. Dunger,et al.  Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants , 2019, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[21]  V. Chau,et al.  Hyperglycemia and Glucose Variability Are Associated with Worse Brain Function and Seizures in Neonatal Encephalopathy: A Prospective Cohort Study. , 2019, The Journal of pediatrics.

[22]  Darrell M. Wilson,et al.  A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring. , 2019, Diabetes technology & therapeutics.

[23]  T. Harrison,et al.  Reducing toxic stress in the neonatal intensive care unit to improve infant outcomes. , 2019, Nursing outlook.

[24]  H. Murphy,et al.  A Feasibility Study of Paired Continuous Glucose Monitoring Intrapartum and in the Newborn in Pregnancies Complicated by Type 1 Diabetes. , 2019, Diabetes technology & therapeutics.

[25]  T. Pieber,et al.  A head‐to‐head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot , 2018, Diabetes, obesity & metabolism.

[26]  G. Freckmann,et al.  Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices , 2018, Journal of diabetes science and technology.

[27]  Chao Chen,et al.  Assessment of the performance of blood glucose monitoring systems for monitoring dysglycaemia in neonatal patients , 2018, BMJ Paediatrics Open.

[28]  D. Dunger,et al.  Targeting glucose control in preterm infants: pilot studies of continuous glucose monitoring , 2018, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[29]  G. Vento,et al.  Continuous glucose monitoring (CGM) in very low birth weight newborns needing parenteral nutrition: validation and glycemic percentiles. , 2018, Italian Journal of Pediatrics.

[30]  K. Beardsall,et al.  Perioperative continuous glucose monitoring in a preterm infant , 2018, BMJ Case Reports.

[31]  J. Geoffrey Chase,et al.  Association of Neonatal Glycemia With Neurodevelopmental Outcomes at 4.5 Years , 2017, JAMA pediatrics.

[32]  Claudio Cobelli,et al.  Continuous Glucose Monitoring in Very Preterm Infants: A Randomized Controlled Trial , 2017, Pediatrics.

[33]  M. Blennow,et al.  Continuous subcutaneous glucose monitoring is accurate in term and near‐term infants at risk of hypoglycaemia , 2016, Acta paediatrica.

[34]  Kexin Xu,et al.  Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes , 2016, Journal of diabetes research.

[35]  C. Romagnoli,et al.  Continuous glucose monitoring in preterm infants: evaluation by a modified Clarke error grid , 2016, Italian Journal of Pediatrics.

[36]  F. Labarthe,et al.  Real-Time Continuous Glucose Monitoring Reduces the Duration of Hypoglycemia Episodes: A Randomized Trial in Very Low Birth Weight Neonates , 2015, PloS one.

[37]  M. Ramón-Krauel,et al.  Instability of glucose values in very preterm babies at term postmenstrual age. , 2014, The Journal of pediatrics.

[38]  A. Schulze,et al.  Clinically stable very low birthweight infants are at risk for recurrent tissue glucose fluctuations even after fully established enteral nutrition , 2014, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[39]  J Geoffrey Chase,et al.  Continuous Glucose Monitoring and Trend Accuracy , 2014, Journal of diabetes science and technology.

[40]  Ronald Brazg,et al.  Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor. , 2014, Diabetes technology & therapeutics.

[41]  J. Chase,et al.  Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial , 2013, The Lancet.

[42]  Ben Feldman,et al.  Metabolic Biofouling of Glucose Sensors in Vivo: Role of Tissue Microhemorrhages , 2011, Journal of diabetes science and technology.

[43]  Ronald Brazg,et al.  FreeStyle Navigator Continuous Glucose Monitoring System with TRUstart Algorithm, a 1-Hour Warm-up Time , 2011, Journal of diabetes science and technology.

[44]  Howard C. Zisser,et al.  Accuracy of the SEVEN® Continuous Glucose Monitoring System: Comparison with Frequently Sampled Venous Glucose Measurements , 2009, Journal of diabetes science and technology.

[45]  W. Tamborlane,et al.  A tale of two compartments: interstitial versus blood glucose monitoring. , 2009, Diabetes technology & therapeutics.

[46]  Christopher R Palmer,et al.  Early insulin therapy in very-low-birth-weight infants. , 2008, The New England journal of medicine.

[47]  D. Dunger,et al.  The continuous glucose monitoring sensor in neonatal intensive care , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[48]  R. Ichord,et al.  Hypoglycemia in the neonate. , 2000, Seminars in perinatology.

[49]  Jennifer L. Dickson,et al.  Continuous Glucose Monitoring Measures Can Be Used for Glycemic Control in the ICU: An In-Silico Study , 2018, Journal of diabetes science and technology.

[50]  J. Jansen,et al.  Influence of inflammatory cells and serum on the performance of implantable glucose sensors. , 2001, Journal of biomedical materials research.